The competition begins in spring 2027, with registration currently open via the AD workbench and Hugging Face. Partners providing data and computational infrastructure include Nvidia, Nebius AI, Talisman Therapeutics, Ultima Genomics, Cellanome, Prime Intellect, and Boltz Bio. The effort follows a recent discovery of a new class of Alzheimer's biomarkers by Goodfire AI and Prima Mente.
Wednesday, October 21, 2026
Story
Prima Mente Launches Alzheimer's AI Competition With 150M Cell Atlas
AI12 days ago
An international team of biotech and technology firms are offering AI researchers access to specialized brain cell data to find new drug targets. The Alzheimer's Translation Challenge, led by Prima Mente and AlzData, uses a 150M cell atlas of neurons, astrocytes, and microglia to identify new therapeutic hypotheses for the disease. Winning participants will have their AI models validated in Prima Mente's wet lab to confirm predicted molecular and functional effects.
Looking for more context or analysis?
Tilt chat provides reliable, tailored insights, alerts, and automations.